Related Experiment Videos
Assessing viable myocardium with thallium-201
1Division of Cardiology, Northwestern University Medical School, Chicago, Illinois 60611.
Insights
Positron emission tomography (PET) scanning and modified thallium imaging protocols can accurately detect viable "hibernating" myocardium in patients with coronary artery disease, even when standard tests are inconclusive. These advanced imaging techniques improve the assessment of myocardial viability.
Area of Science:
- Cardiology
- Nuclear Medicine
- Medical Imaging
Background:
- Chronic coronary artery disease can lead to left ventricular dysfunction.
- Myocardial viability assessment is crucial for managing these patients.
- Standard indicators like wall motion and perfusion may not always detect hibernating myocardium.
Purpose of the Study:
- To evaluate advanced imaging techniques for detecting myocardial viability.
- To identify viable myocardium in patients with seemingly irreversible defects.
Main Methods:
- Positron emission tomography (PET) scanning to assess metabolic activity.
- Modified thallium-201 protocols including late redistribution (8-72 hours) and reinjection imaging.
- Serial resting thallium-201 imaging.
Main Results:
- PET scanning accurately identifies preserved metabolic activity in hibernating myocardium.
- Modified thallium protocols detect viable myocardium missed by standard imaging.
- Late redistribution and reinjection imaging reveal viability in apparently irreversible defects.
Conclusions:
- Advanced imaging, including PET and modified thallium protocols, enhances the detection of myocardial viability.
- These methods are valuable for evaluating and managing patients with coronary artery disease and left ventricular dysfunction.
- Accurate assessment of myocardial viability guides therapeutic decisions.
Abstract:
Patients with chronic coronary artery disease and potentially reversible left ventricular dysfunction can often be successfully identified by one or more clinical indicators of myocardial viability, including regional wall motion, systolic wall thickening, regional myocardial perfusion as determined by perfusion tracers, and redistribution of thallium-201. In some patients, however, viable but "hibernating" myocardium will exist even when none of the above are evident. Myocardial viability in this situation can be detected with a high degree of accuracy by the demonstration of preserved metabolic activity by positron emission tomography (PET) scanning. Additionally, modifications of the standard exercise-redistribution thallium protocol may also produce accurate results. These modifications include late thallium-201 redistribution imaging, performed 8-72 hours following initial thallium injection, and thallium reinjection at rest after early (3-4 hours) or late (8-72 hours) redistribution imaging. These methods can identify viable myocardium in many thallium defects that appear to be irreversible on a standard 3-4 hour redistribution image. In addition, serial imaging after administration of thallium-201 at rest may also provide valuable insights into myocardial viability. These imaging modalities have important practical applications in the evaluation and management of patients with coronary artery disease and left ventricular dysfunction.